Detalhe da pesquisa
1.
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.
J Natl Compr Canc Netw
; 19(3): 254-266, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33668021
2.
Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome.
BMC Cancer
; 19(1): 70, 2019 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30642285
3.
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020.
J Natl Compr Canc Netw
; 17(12): 1464-1472, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31805526
4.
Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial.
Cancer
; 124(13): 2841-2849, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29669181
5.
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.
Lancet Oncol
; 17(11): 1497-1508, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27745820
6.
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment.
Cancer
; 121(16): 2749-56, 2015 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25913680
7.
Neutrophil to lymphocyte ratio and peripheral blood biomarkers correlate with survival outcomes but not response among head and neck and salivary cancer treated with pembrolizumab and vorinostat.
Head Neck
; 45(2): 391-397, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36412064
8.
Peripheral lymphocytes and lactate dehydrogenase correlate with response and survival in head and neck cancers treated with immune checkpoint inhibitors.
Cancer Med
; 12(8): 9384-9391, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36806947
9.
A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer.
BMC Cancer
; 12: 449, 2012 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23033932
10.
The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement.
J Natl Compr Canc Netw
; 10(5): 599-613, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22570291
11.
Impact of Diagnostic Delays on Lung Cancer Survival Outcomes: A Population Study of the US SEER-Medicare Database.
JCO Oncol Pract
; 18(6): e877-e885, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35119911
12.
High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors.
J Palliat Med
; 25(4): 614-619, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34847733
13.
Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients.
Cancer Med
; 11(22): 4104-4111, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349227
14.
Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer.
Adv Radiat Oncol
; 7(2): 100857, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35387421
15.
Value-Based Care in Lung Cancer.
Oncologist
; 21(8): 903-6, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27256872
16.
Motesanib diphosphate in progressive differentiated thyroid cancer.
N Engl J Med
; 359(1): 31-42, 2008 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-18596272
17.
Adaptive Fluorodeoxyglucose-Positron Emission Tomography Based Chemotherapy Selection for Metastatic Non-small Cell Lung Cancer.
Cureus
; 13(10): e18804, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34796077
18.
Impact of Clinical Trial Participation on Survival of Patients with Metastatic Non-Small Cell Lung Cancer.
Clin Lung Cancer
; 22(6): 523-530, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34059474
19.
Effect of Clinical Trial Participation on Costs to Payers in Metastatic Non-Small-Cell Lung Cancer.
JCO Oncol Pract
; 17(8): e1225-e1234, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34375561
20.
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC.
J Thorac Oncol
; 16(1): 162-168, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33069888